_version_ 1784791936224198656
author Graves, Paul R.
Aponte-Collazo, Lucas J.
Fennell, Emily M. J.
Graves, Adam C.
Hale, Andrew E.
Dicheva, Nedyalka
Herring, Laura E.
Gilbert, Thomas S. K.
East, Michael P.
McDonald, Ian M.
Lockett, Matthew R.
Ashamalla, Hani
Moorman, Nathaniel J.
Karanewsky, Donald S.
Iwanowicz, Edwin J.
Holmuhamedov, Ekhson
Graves, Lee M.
author_facet Graves, Paul R.
Aponte-Collazo, Lucas J.
Fennell, Emily M. J.
Graves, Adam C.
Hale, Andrew E.
Dicheva, Nedyalka
Herring, Laura E.
Gilbert, Thomas S. K.
East, Michael P.
McDonald, Ian M.
Lockett, Matthew R.
Ashamalla, Hani
Moorman, Nathaniel J.
Karanewsky, Donald S.
Iwanowicz, Edwin J.
Holmuhamedov, Ekhson
Graves, Lee M.
author_sort Graves, Paul R.
collection PubMed
description
format Online
Article
Text
id pubmed-9484722
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-94847222022-09-20 Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues” Graves, Paul R. Aponte-Collazo, Lucas J. Fennell, Emily M. J. Graves, Adam C. Hale, Andrew E. Dicheva, Nedyalka Herring, Laura E. Gilbert, Thomas S. K. East, Michael P. McDonald, Ian M. Lockett, Matthew R. Ashamalla, Hani Moorman, Nathaniel J. Karanewsky, Donald S. Iwanowicz, Edwin J. Holmuhamedov, Ekhson Graves, Lee M. ACS Chem Biol American Chemical Society 2022-07-25 2022-08-19 /pmc/articles/PMC9484722/ /pubmed/35878877 http://dx.doi.org/10.1021/acschembio.2c00545 Text en © 2022 American Chemical Society https://pubs.acs.org/page/policy/authorchoice_termsofuse.htmlThis is an open access article published under an ACS AuthorChoice License (https://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Graves, Paul R.
Aponte-Collazo, Lucas J.
Fennell, Emily M. J.
Graves, Adam C.
Hale, Andrew E.
Dicheva, Nedyalka
Herring, Laura E.
Gilbert, Thomas S. K.
East, Michael P.
McDonald, Ian M.
Lockett, Matthew R.
Ashamalla, Hani
Moorman, Nathaniel J.
Karanewsky, Donald S.
Iwanowicz, Edwin J.
Holmuhamedov, Ekhson
Graves, Lee M.
Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
title Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
title_full Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
title_fullStr Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
title_full_unstemmed Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
title_short Correction to “Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues”
title_sort correction to “mitochondrial protease clpp is a target for the anticancer compounds onc201 and related analogues”
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484722/
https://www.ncbi.nlm.nih.gov/pubmed/35878877
http://dx.doi.org/10.1021/acschembio.2c00545
work_keys_str_mv AT gravespaulr correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT apontecollazolucasj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT fennellemilymj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT gravesadamc correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT haleandrewe correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT dichevanedyalka correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT herringlaurae correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT gilbertthomassk correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT eastmichaelp correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT mcdonaldianm correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT lockettmatthewr correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT ashamallahani correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT moormannathanielj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT karanewskydonalds correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT iwanowiczedwinj correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT holmuhamedovekhson correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues
AT gravesleem correctiontomitochondrialproteaseclppisatargetfortheanticancercompoundsonc201andrelatedanalogues